<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2017-12-20" version="227">
<accession>P02649</accession>
<accession>B2RC15</accession>
<accession>C0JYY5</accession>
<accession>Q9P2S4</accession>
<name>APOE_HUMAN</name>
<protein>
<recommendedName>
<fullName>Apolipoprotein E</fullName>
<shortName>Apo-E</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary">APOE</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1984" name="J. Biol. Chem." volume="259" first="5495" last="5499">
<title>Synthesis, intracellular processing, and signal peptide of human apolipoprotein E.</title>
<authorList>
<person name="Zannis V.I."/>
<person name="McPherson J."/>
<person name="Goldberger G."/>
<person name="Karathanasis S.K."/>
<person name="Breslow J.L."/>
</authorList>
<dbReference type="PubMed" id="6325438"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (VARIANT E3)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1984" name="J. Biol. Chem." volume="259" first="6498" last="6504">
<title>Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant.</title>
<authorList>
<person name="McLean J.W."/>
<person name="Elshourbagy N.A."/>
<person name="Chang D.J."/>
<person name="Mahley R.W."/>
<person name="Taylor J.M."/>
</authorList>
<dbReference type="PubMed" id="6327682"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (VARIANT E3)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1985" name="Proc. Natl. Acad. Sci. U.S.A." volume="82" first="3445" last="3449">
<title>Nucleotide sequence and structure of the human apolipoprotein E gene.</title>
<authorList>
<person name="Paik Y.-K."/>
<person name="Chang D.J."/>
<person name="Reardon C.A."/>
<person name="Davies G.E."/>
<person name="Mahley R.W."/>
<person name="Taylor J.M."/>
</authorList>
<dbReference type="PubMed" id="2987927"/>
<dbReference type="DOI" id="10.1073/pnas.82.10.3445"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (VARIANT E4)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1988" name="Genomics" volume="3" first="373" last="379">
<title>Genotyping and sequence analysis of apolipoprotein E isoforms.</title>
<authorList>
<person name="Emi M."/>
<person name="Wu L.L."/>
<person name="Robertson M.A."/>
<person name="Myers R.L."/>
<person name="Hegele R.A."/>
<person name="Williams R.R."/>
<person name="White R."/>
<person name="Lalouel J.-M."/>
</authorList>
<dbReference type="PubMed" id="3243553"/>
<dbReference type="DOI" id="10.1016/0888-7543(88)90130-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (VARIANT E2)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1998" name="DNA Seq." volume="9" first="89" last="100">
<title>Sequencing of 42kb of the APO E-C2 gene cluster reveals a new gene: PEREC1.</title>
<authorList>
<person name="Freitas E.M."/>
<person name="Zhang W.J."/>
<person name="Lalonde J.P."/>
<person name="Tay G.K."/>
<person name="Gaudieri S."/>
<person name="Ashworth L.K."/>
<person name="Van Bockxmeer F.M."/>
<person name="Dawkins R.L."/>
</authorList>
<dbReference type="PubMed" id="10520737"/>
<dbReference type="DOI" id="10.3109/10425179809086433"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Genome Res." volume="10" first="1532" last="1545">
<title>Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene.</title>
<authorList>
<person name="Nickerson D.A."/>
<person name="Taylor S.L."/>
<person name="Fullerton S.M."/>
<person name="Weiss K.M."/>
<person name="Clark A.G."/>
<person name="Stengard J.H."/>
<person name="Salomaa V."/>
<person name="Boerwinkle E."/>
<person name="Sing C.F."/>
</authorList>
<dbReference type="PubMed" id="11042151"/>
<dbReference type="DOI" id="10.1101/gr.146900"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS PRO-46; ARG-130; CYS-163 AND CYS-176</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2008-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Eye</tissue>
</source>
</reference>
<reference key="10">
<citation type="submission" date="1999-11" db="EMBL/GenBank/DDBJ databases">
<title>A new apolipoprotein E variant (Gln46-->His).</title>
<authorList>
<person name="Imura T."/>
<person name="Kimura H."/>
<person name="Kawasaki M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 16-78</scope>
<scope>VARIANT HIS-64</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1982" name="J. Biol. Chem." volume="257" first="14639" last="14641">
<title>Identification and DNA sequence of a human apolipoprotein E cDNA clone.</title>
<authorList>
<person name="Breslow J.L."/>
<person name="McPherson J."/>
<person name="Nussbaum A.L."/>
<person name="Williams H.W."/>
<person name="Lofquist-Kahl F."/>
<person name="Karathanasis S.K."/>
<person name="Zannis V.I."/>
</authorList>
<dbReference type="PubMed" id="6897404"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 99-317 (VARIANT E3)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1983" name="J. Biol. Chem." volume="258" first="11422" last="11422">
<authorList>
<person name="Breslow J.L."/>
<person name="McPherson J."/>
<person name="Nussbaum A.L."/>
<person name="Williams H.W."/>
<person name="Lofquist-Kahl F."/>
<person name="Karathanasis S.K."/>
<person name="Zannis V.I."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1982" name="J. Biol. Chem." volume="257" first="4171" last="4178">
<title>Human apolipoprotein E. The complete amino acid sequence.</title>
<authorList>
<person name="Rall S.C. Jr."/>
<person name="Weisgraber K.H."/>
<person name="Mahley R.W."/>
</authorList>
<dbReference type="PubMed" id="7068630"/>
</citation>
<scope>PROTEIN SEQUENCE OF 19-317 (VARIANT E2)</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1988" name="Science" volume="240" first="622" last="630">
<title>Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.</title>
<authorList>
<person name="Mahley R.W."/>
</authorList>
<dbReference type="PubMed" id="3283935"/>
<dbReference type="DOI" id="10.1126/science.3283935"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1986" name="Biochem. Biophys. Res. Commun." volume="134" first="783" last="789">
<title>Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains.</title>
<authorList>
<person name="Cardin A.D."/>
<person name="Hirose N."/>
<person name="Blankenship D.T."/>
<person name="Jackson R.L."/>
<person name="Harmony J.A.K."/>
<person name="Sparrow D.A."/>
<person name="Sparrow J.T."/>
</authorList>
<dbReference type="PubMed" id="3947350"/>
<dbReference type="DOI" id="10.1016/S0006-291X(86)80489-2"/>
</citation>
<scope>HEPARIN-BINDING SITES</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1993" name="Science" volume="261" first="921" last="923">
<title>Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.</title>
<authorList>
<person name="Corder E.H."/>
<person name="Saunders A.M."/>
<person name="Strittmatter W.J."/>
<person name="Schmechel D.E."/>
<person name="Gaskell P.C."/>
<person name="Small G.W."/>
<person name="Roses A.D."/>
<person name="Haines J.L."/>
<person name="Pericak-Vance M.A."/>
</authorList>
<dbReference type="PubMed" id="8346443"/>
<dbReference type="DOI" id="10.1126/science.8346443"/>
</citation>
<scope>INVOLVEMENT IN AD2</scope>
<scope>VARIANT AD2 ARG-130</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="Biochim. Biophys. Acta" volume="1454" first="296" last="308">
<title>Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site.</title>
<authorList>
<person name="Shuvaev V.V."/>
<person name="Fujii J."/>
<person name="Kawasaki Y."/>
<person name="Itoh H."/>
<person name="Hamaoka R."/>
<person name="Barbier A."/>
<person name="Ziegler O."/>
<person name="Siest G."/>
<person name="Taniguchi N."/>
</authorList>
<dbReference type="PubMed" id="10452964"/>
<dbReference type="DOI" id="10.1016/S0925-4439(99)00047-2"/>
</citation>
<scope>GLYCATION AT LYS-93</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Nat. Methods" volume="6" first="809" last="811">
<title>Enrichment of glycopeptides for glycan structure and attachment site identification.</title>
<authorList>
<person name="Nilsson J."/>
<person name="Rueetschi U."/>
<person name="Halim A."/>
<person name="Hesse C."/>
<person name="Carlsohn E."/>
<person name="Brinkmalm G."/>
<person name="Larson G."/>
</authorList>
<dbReference type="PubMed" id="19838169"/>
<dbReference type="DOI" id="10.1038/nmeth.1392"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT THR-212; THR-307 AND SER-308</scope>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<source>
<tissue>Cerebrospinal fluid</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2012" name="J. Proteome Res." volume="11" first="4733" last="4743">
<title>Resveratrol-induced changes of the human adipocyte secretion profile.</title>
<authorList>
<person name="Rosenow A."/>
<person name="Noben J.P."/>
<person name="Jocken J."/>
<person name="Kallendrusch S."/>
<person name="Fischer-Posovszky P."/>
<person name="Mariman E.C."/>
<person name="Renes J."/>
</authorList>
<dbReference type="PubMed" id="22905912"/>
<dbReference type="DOI" id="10.1021/pr300539b"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="573" last="584">
<title>LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins.</title>
<authorList>
<person name="Halim A."/>
<person name="Ruetschi U."/>
<person name="Larson G."/>
<person name="Nilsson J."/>
</authorList>
<dbReference type="PubMed" id="23234360"/>
<dbReference type="DOI" id="10.1021/pr300963h"/>
</citation>
<scope>GLYCOSYLATION AT THR-26; THR-36 AND SER-314</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-147</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2015" name="Cell" volume="161" first="1619" last="1632">
<title>A single kinase generates the majority of the secreted phosphoproteome.</title>
<authorList>
<person name="Tagliabracci V.S."/>
<person name="Wiley S.E."/>
<person name="Guo X."/>
<person name="Kinch L.N."/>
<person name="Durrant E."/>
<person name="Wen J."/>
<person name="Xiao J."/>
<person name="Cui J."/>
<person name="Nguyen K.B."/>
<person name="Engel J.L."/>
<person name="Coon J.J."/>
<person name="Grishin N."/>
<person name="Pinna L.A."/>
<person name="Pagliarini D.J."/>
<person name="Dixon J.E."/>
</authorList>
<dbReference type="PubMed" id="26091039"/>
<dbReference type="DOI" id="10.1016/j.cell.2015.05.028"/>
</citation>
<scope>PHOSPHORYLATION AT SER-147</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1991" name="Science" volume="252" first="1817" last="1822">
<title>Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E.</title>
<authorList>
<person name="Wilson C."/>
<person name="Wardell M.R."/>
<person name="Weisgraber K.H."/>
<person name="Mahley R.W."/>
<person name="Agard D.A."/>
</authorList>
<dbReference type="PubMed" id="2063194"/>
<dbReference type="DOI" id="10.1126/science.2063194"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 41-184</scope>
<scope>LDL RECEPTOR BINDING REGION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1996" name="Nat. Struct. Biol." volume="3" first="718" last="722">
<title>Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia.</title>
<authorList>
<person name="Dong L.-M."/>
<person name="Parkin S."/>
<person name="Trakhanov S.D."/>
<person name="Rupp B."/>
<person name="Simmons T."/>
<person name="Arnold K.S."/>
<person name="Newhouse Y.M."/>
<person name="Innerarity T.L."/>
<person name="Weisgraber K.H."/>
</authorList>
<dbReference type="PubMed" id="8756331"/>
<dbReference type="DOI" id="10.1038/nsb0896-718"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 41-181</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2000" name="Protein Sci." volume="9" first="886" last="897">
<title>Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: implications for lipid binding.</title>
<authorList>
<person name="Segelke B.W."/>
<person name="Forstner M."/>
<person name="Knapp M."/>
<person name="Trakhanov S.D."/>
<person name="Parkin S."/>
<person name="Newhouse Y.M."/>
<person name="Bellamy H.D."/>
<person name="Weisgraber K.H."/>
<person name="Rupp B."/>
</authorList>
<dbReference type="PubMed" id="10850798"/>
<dbReference type="DOI" id="10.1110/ps.9.5.886"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 22-165</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1994" name="Hum. Mutat." volume="4" first="178" last="194">
<title>Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.</title>
<authorList>
<person name="de Knijff P."/>
<person name="van den Maagdenberg A.M.J.M."/>
<person name="Frants R.R."/>
<person name="Havekes L.M."/>
</authorList>
<dbReference type="PubMed" id="7833947"/>
<dbReference type="DOI" id="10.1002/humu.1380040303"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1989" name="J. Biochem." volume="105" first="491" last="493">
<title>Molecular cloning of a human apolipoprotein E variant: E5 (Glu-3-->Lys).</title>
<authorList>
<person name="Maeda H."/>
<person name="Nakamura H."/>
<person name="Kobori S."/>
<person name="Okada M."/>
<person name="Niki H."/>
<person name="Ogura T."/>
<person name="Hiraga S."/>
</authorList>
<dbReference type="PubMed" id="2760009"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.jbchem.a122692"/>
</citation>
<scope>VARIANT E5 LYS-21</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1989" name="J. Biol. Chem." volume="264" first="21205" last="21210">
<title>Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121-127.</title>
<authorList>
<person name="Wardell M.R."/>
<person name="Weisgraber K.H."/>
<person name="Havekes L.M."/>
<person name="Rall S.C. Jr."/>
</authorList>
<dbReference type="PubMed" id="2556398"/>
</citation>
<scope>VARIANT HLPP3 E3 LEIDEN GLU-VAL-GLN-ALA-MET-LEU-GLY-145 INS</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="10479" last="10484">
<title>Apolipoprotein E-4 Philadelphia (Glu-13-->Lys,Arg-145-->Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia.</title>
<authorList>
<person name="Lohse P."/>
<person name="Mann W.A."/>
<person name="Stein E.A."/>
<person name="Brewer H.B. Jr."/>
</authorList>
<dbReference type="PubMed" id="1674745"/>
</citation>
<scope>VARIANTS HLPP3 E4 PHILADELPHIA LYS-31 AND CYS-163</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1993" name="Am. J. Hum. Genet." volume="52" first="937" last="946">
<title>Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia.</title>
<authorList>
<person name="van den Maagdenberg A.M.J.M."/>
<person name="Weng W."/>
<person name="de Bruijn I.H."/>
<person name="de Knijff P."/>
<person name="Funke H."/>
<person name="Smelt A.H.M."/>
<person name="Leuven J.A.G."/>
<person name="van 't Hooft F.M."/>
<person name="Assmann G."/>
<person name="Hofker M.H."/>
<person name="Havekes L.M."/>
<person name="Frants R.R."/>
</authorList>
<dbReference type="PubMed" id="8488843"/>
</citation>
<scope>VARIANTS GLU-254; GLY-269; GLU-270; HIS-292 AND ARG-314</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1994" name="Clin. Chem." volume="40" first="24" last="29">
<title>Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA.</title>
<authorList>
<person name="Richard P."/>
<person name="Thomas G."/>
<person name="de Zulueta M.P."/>
<person name="de Gennes J.-L."/>
<person name="Thomas M."/>
<person name="Cassaigne A."/>
<person name="Bereziat G."/>
<person name="Iron A."/>
</authorList>
<dbReference type="PubMed" id="8287539"/>
</citation>
<scope>VARIANTS HLPP3 ARG-130; ASP-145; SER-154; CYS-160 AND CYS-176</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1997" name="J. Am. Soc. Nephrol." volume="8" first="820" last="823">
<title>Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.</title>
<authorList>
<person name="Oikawa S."/>
<person name="Matsunaga A."/>
<person name="Saito T."/>
<person name="Sato H."/>
<person name="Seki T."/>
<person name="Hoshi K."/>
<person name="Hayasaka K."/>
<person name="Kotake H."/>
<person name="Midorikawa H."/>
<person name="Sekikawa A."/>
<person name="Hara S."/>
<person name="Abe K."/>
<person name="Toyota T."/>
<person name="Jingami H."/>
<person name="Nakamura H."/>
<person name="Sasaki J."/>
</authorList>
<dbReference type="PubMed" id="9176854"/>
</citation>
<scope>VARIANT LPG PRO-163</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1997" name="Mutat. Res." volume="382" first="57" last="65">
<title>Apolipoprotein E R112; R251G: a carboxy-terminal variant found in patients with hyperlipidemia and coronary heart disease.</title>
<authorList>
<person name="Kang A.K."/>
<person name="Jenkins D.J.A."/>
<person name="Wolever T.M.S."/>
<person name="Huff M.W."/>
<person name="Maguire G.F."/>
<person name="Connelly P.W."/>
<person name="Hegele R.A."/>
</authorList>
<dbReference type="PubMed" id="9360638"/>
<dbReference type="DOI" id="10.1016/S1383-5726(97)00009-5"/>
</citation>
<scope>VARIANTS E4/3 ARG-130 AND GLY-269</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1999" name="Kidney Int." volume="56" first="421" last="427">
<title>A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.</title>
<authorList>
<person name="Matsunaga A."/>
<person name="Sasaki J."/>
<person name="Komatsu T."/>
<person name="Kanatsu K."/>
<person name="Tsuji E."/>
<person name="Moriyama K."/>
<person name="Koga T."/>
<person name="Arakawa K."/>
<person name="Oikawa S."/>
<person name="Saito T."/>
<person name="Kita T."/>
<person name="Doi T."/>
</authorList>
<dbReference type="PubMed" id="10432380"/>
<dbReference type="DOI" id="10.1046/j.1523-1755.1999.00572.x"/>
</citation>
<scope>VARIANT LPG CYS-43</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2000" name="J. Clin. Endocrinol. Metab." volume="85" first="4354" last="4358">
<title>Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)].</title>
<authorList>
<person name="Nguyen T.T."/>
<person name="Kruckeberg K.E."/>
<person name="O'Brien J.F."/>
<person name="Ji Z.-S."/>
<person name="Karnes P.S."/>
<person name="Crotty T.B."/>
<person name="Hay I.D."/>
<person name="Mahley R.W."/>
<person name="O'Brien T."/>
</authorList>
<dbReference type="PubMed" id="11095479"/>
<dbReference type="DOI" id="10.1210/jcem.85.11.6981"/>
</citation>
<scope>VARIANT SBHD LEU-167 DEL</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2003" name="Eur. J. Clin. Invest." volume="33" first="677" last="685">
<title>Apolipoprotein E3Basel: new insights into a highly conserved protein region.</title>
<authorList>
<person name="Miserez A.R."/>
<person name="Scharnagl H."/>
<person name="Muller P.Y."/>
<person name="Mirsaidi R."/>
<person name="Stahelin H.B."/>
<person name="Monsch A."/>
<person name="Marz W."/>
<person name="Hoffmann M.M."/>
</authorList>
<dbReference type="PubMed" id="12864777"/>
<dbReference type="DOI" id="10.1046/j.1365-2362.2003.01180.x"/>
</citation>
<scope>VARIANT E3 BASEL VAL-124</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="2733" last="2743">
<title>Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors.</title>
<authorList>
<person name="Morabia A."/>
<person name="Cayanis E."/>
<person name="Costanza M.C."/>
<person name="Ross B.M."/>
<person name="Flaherty M.S."/>
<person name="Alvin G.B."/>
<person name="Das K."/>
<person name="Gilliam T.C."/>
</authorList>
<dbReference type="PubMed" id="12966036"/>
<dbReference type="DOI" id="10.1093/hmg/ddg314"/>
</citation>
<scope>VARIANTS ARG-130 AND CYS-176</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2005" name="Eur. J. Hum. Genet." volume="13" first="1186" last="1191">
<title>Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation.</title>
<authorList>
<person name="Faivre L."/>
<person name="Saugier-Veber P."/>
<person name="Pais de Barros J.-P."/>
<person name="Verges B."/>
<person name="Couret B."/>
<person name="Lorcerie B."/>
<person name="Thauvin C."/>
<person name="Charbonnier F."/>
<person name="Huet F."/>
<person name="Gambert P."/>
<person name="Frebourg T."/>
<person name="Duvillard L."/>
</authorList>
<dbReference type="PubMed" id="16094309"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5201480"/>
</citation>
<scope>VARIANT SBHD LEU-167 DEL</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="N. Engl. J. Med." volume="357" first="2522" last="2524">
<title>APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy.</title>
<authorList>
<person name="Rovin B.H."/>
<person name="Roncone D."/>
<person name="McKinley A."/>
<person name="Nadasdy T."/>
<person name="Korbet S.M."/>
<person name="Schwartz M.M."/>
</authorList>
<dbReference type="PubMed" id="18077821"/>
<dbReference type="DOI" id="10.1056/NEJMc072088"/>
</citation>
<scope>VARIANT LPG CYS-43</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="J. Mol. Cell Biol." volume="3" first="309" last="315">
<title>Quantitative detection of single amino acid polymorphisms by targeted proteomics.</title>
<authorList>
<person name="Su Z.D."/>
<person name="Sun L."/>
<person name="Yu D.X."/>
<person name="Li R.X."/>
<person name="Li H.X."/>
<person name="Yu Z.J."/>
<person name="Sheng Q.H."/>
<person name="Lin X."/>
<person name="Zeng R."/>
<person name="Wu J.R."/>
</authorList>
<dbReference type="PubMed" id="22028381"/>
<dbReference type="DOI" id="10.1093/jmcb/mjr024"/>
</citation>
<scope>VARIANT HIS-64</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="Atherosclerosis" volume="222" first="449" last="455">
<title>Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia.</title>
<authorList>
<person name="Solanas-Barca M."/>
<person name="de Castro-Oros I."/>
<person name="Mateo-Gallego R."/>
<person name="Cofan M."/>
<person name="Plana N."/>
<person name="Puzo J."/>
<person name="Burillo E."/>
<person name="Martin-Fuentes P."/>
<person name="Ros E."/>
<person name="Masana L."/>
<person name="Pocovi M."/>
<person name="Civeira F."/>
<person name="Cenarro A."/>
</authorList>
<dbReference type="PubMed" id="22481068"/>
<dbReference type="DOI" id="10.1016/j.atherosclerosis.2012.03.011"/>
</citation>
<scope>VARIANT HLPP3 SER-154</scope>
<scope>VARIANT LEU-167 DEL</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2013" name="Atherosclerosis" volume="231" first="218" last="222">
<title>APOE p.Leu167del mutation in familial hypercholesterolemia.</title>
<authorList>
<person name="Awan Z."/>
<person name="Choi H.Y."/>
<person name="Stitziel N."/>
<person name="Ruel I."/>
<person name="Bamimore M.A."/>
<person name="Husa R."/>
<person name="Gagnon M.H."/>
<person name="Wang R.H."/>
<person name="Peloso G.M."/>
<person name="Hegele R.A."/>
<person name="Seidah N.G."/>
<person name="Kathiresan S."/>
<person name="Genest J."/>
</authorList>
<dbReference type="PubMed" id="24267230"/>
<dbReference type="DOI" id="10.1016/j.atherosclerosis.2013.09.007"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN FH</scope>
<scope>VARIANT FH LEU-167 DEL</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2013" name="Hum. Mutat." volume="34" first="83" last="87">
<title>Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation.</title>
<authorList>
<person name="Marduel M."/>
<person name="Ouguerram K."/>
<person name="Serre V."/>
<person name="Bonnefont-Rousselot D."/>
<person name="Marques-Pinheiro A."/>
<person name="Erik Berge K."/>
<person name="Devillers M."/>
<person name="Luc G."/>
<person name="Lecerf J.M."/>
<person name="Tosolini L."/>
<person name="Erlich D."/>
<person name="Peloso G.M."/>
<person name="Stitziel N."/>
<person name="Nitchke P."/>
<person name="Jais J.P."/>
<person name="Abifadel M."/>
<person name="Kathiresan S."/>
<person name="Leren T.P."/>
<person name="Rabes J.P."/>
<person name="Boileau C."/>
<person name="Varret M."/>
</authorList>
<dbReference type="PubMed" id="22949395"/>
<dbReference type="DOI" id="10.1002/humu.22215"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN FH</scope>
<scope>VARIANT FH LEU-167 DEL</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2016" name="J. Lipid Res." volume="57" first="482" last="491">
<title>Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.</title>
<authorList>
<person name="Wintjens R."/>
<person name="Bozon D."/>
<person name="Belabbas K."/>
<person name="Mbou F."/>
<person name="Girardet J.P."/>
<person name="Tounian P."/>
<person name="Jolly M."/>
<person name="Boccara F."/>
<person name="Cohen A."/>
<person name="Karsenty A."/>
<person name="Dubern B."/>
<person name="Carel J.C."/>
<person name="Azar-Kolakez A."/>
<person name="Feillet F."/>
<person name="Labarthe F."/>
<person name="Gorsky A.M."/>
<person name="Horovitz A."/>
<person name="Tamarindi C."/>
<person name="Kieffer P."/>
<person name="Lienhardt A."/>
<person name="Lascols O."/>
<person name="Di Filippo M."/>
<person name="Dufernez F."/>
</authorList>
<dbReference type="PubMed" id="26802169"/>
<dbReference type="DOI" id="10.1194/jlr.P055699"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN FH</scope>
<scope>VARIANTS FH PRO-46; ASP-145; CYS-163 AND LEU-167 DEL</scope>
</reference>
<comment type="function">
<text evidence="37">Mediates the binding, internalization, and catabolism of lipoprotein particles. It can serve as a ligand for the LDL (apo B/E) receptor and for the specific apo-E receptor (chylomicron remnant) of hepatic tissues.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222467"/>
<interactant intactId="EBI-6904269">
<id>P27958</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222467"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222467"/>
<interactant intactId="EBI-712452">
<id>Q9BQ95</id>
<label>ECSIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222467"/>
<interactant intactId="EBI-1220767">
<id>P00738</id>
<label>HP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222467"/>
<interactant intactId="EBI-988319">
<id>P01130</id>
<label>LDLR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222467"/>
<interactant intactId="EBI-2681187">
<id>Q14114</id>
<label>LRP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9209835"/>
<interactant intactId="EBI-366182">
<id>P10636</id>
<label>MAPT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222467"/>
<interactant intactId="EBI-935824">
<id>Q53EL6</id>
<label>PDCD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222467"/>
<interactant intactId="EBI-357285">
<id>P50502</id>
<label>ST13</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1222467"/>
<interactant intactId="EBI-726731">
<id>O75069</id>
<label>TMCC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="37">Secreted</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>Occurs in all lipoprotein fractions in plasma. It constitutes 10-20% of very low density lipoproteins (VLDL) and 1-2% of high density lipoproteins (HDL). APOE is produced in most organs. Significant quantities are produced in liver, brain, spleen, lung, adrenal, ovary, kidney and muscle.</text>
</comment>
<comment type="PTM">
<text evidence="18 23">Synthesized with the sialic acid attached by O-glycosidic linkage and is subsequently desialylated in plasma. O-glycosylated with core 1 or possibly core 8 glycans. Thr-307 and Ser-314 are minor glycosylation sites compared to Ser-308.</text>
</comment>
<comment type="PTM">
<text>Glycated in plasma VLDL of normal subjects, and of hyperglycemic diabetic patients at a higher level (2-3 fold).</text>
</comment>
<comment type="PTM">
<text evidence="26">Phosphorylated by FAM20C in the extracellular medium.</text>
</comment>
<comment type="polymorphism">
<text evidence="38">Three common APOE alleles have been identified: APOE*2, APOE*3, and APOE*4. The corresponding three major isoforms, E2, E3, and E4, are recognized according to their relative position after isoelectric focusing. Different mutations causing the same migration pattern after isoelectric focusing define different isoform subtypes. The most common isoform is E3 and is present in 40-90% of the population. Common APOE variants influence lipoprotein metabolism in healthy individuals.</text>
</comment>
<comment type="disease" evidence="16 21 25 31">
<disease id="DI-01771">
<name>Hyperlipoproteinemia 3</name>
<acronym>HLPP3</acronym>
<description>A disorder characterized by the accumulation of intermediate-density lipoprotein particles (IDL or broad-beta-lipoprotein) rich in cholesterol. Clinical features include xanthomas, yellowish lipid deposits in the palmar crease, or less specific on tendons and on elbows. The disorder rarely manifests before the third decade in men. In women, it is usually expressed only after the menopause.</description>
<dbReference type="MIM" id="617347"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry. The vast majority of the patients are homozygous for APOE*2 alleles. More severe cases of HLPP3 have also been observed in individuals heterozygous for rare APOE variants. The influence of APOE on lipid levels is often suggested to have major implications for the risk of coronary artery disease (CAD). Individuals carrying the common APOE*4 variant are at higher risk of CAD.</text>
</comment>
<comment type="disease" evidence="32">
<disease id="DI-02694">
<name>Alzheimer disease 2</name>
<acronym>AD2</acronym>
<description>A late-onset form of Alzheimer disease. Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death.</description>
<dbReference type="MIM" id="104310"/>
</disease>
<text evidence="32">Disease susceptibility is associated with variations affecting the gene represented in this entry. The APOE*4 allele (APOE form E4) is genetically associated with the common late onset familial and sporadic forms of Alzheimer disease. Risk for AD increased from 20% to 90% and mean age at onset decreased from 84 to 68 years with increasing number of APOE*4 alleles in 42 families with late onset AD. Thus APOE*4 gene dose is a major risk factor for late onset AD and, in these families, homozygosity for APOE*4 was virtually sufficient to cause AD by age 80. The mechanism by which APOE*4 participates in pathogenesis is not known.</text>
</comment>
<comment type="disease" evidence="12 15">
<disease id="DI-02290">
<name>Sea-blue histiocyte disease</name>
<acronym>SBHD</acronym>
<description>Characterized by splenomegaly, mild thrombocytopenia and, in the bone marrow, numerous histiocytes containing cytoplasmic granules which stain bright blue with the usual hematologic stains. The syndrome is the consequence of an inherited metabolic defect analogous to Gaucher disease and other sphingolipidoses.</description>
<dbReference type="MIM" id="269600"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="10 17 34">
<disease id="DI-01910">
<name>Lipoprotein glomerulopathy</name>
<acronym>LPG</acronym>
<description>Uncommon kidney disease characterized by proteinuria, progressive kidney failure, and distinctive lipoprotein thrombi in glomerular capillaries.</description>
<dbReference type="MIM" id="611771"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="22 24 27">
<disease id="DI-01577">
<name>Familial hypercholesterolemia</name>
<acronym>FH</acronym>
<description>Common autosomal semi-dominant disease that affects about 1 in 500 individuals. The receptor defect impairs the catabolism of LDL, and the resultant elevation in plasma LDL-cholesterol promotes deposition of cholesterol in the skin (xanthelasma), tendons (xanthomas), and coronary arteries (atherosclerosis).</description>
<dbReference type="MIM" id="143890"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="38">Belongs to the apolipoprotein A1/A4/E family.</text>
</comment>
<comment type="online information" name="SHMPD">
<link uri="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&amp;genename=APOE"/>
<text>The Singapore human mutation and polymorphism database</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Apolipoprotein_E"/>
<text>Apolipoprotein E entry</text>
</comment>
<comment type="online information" name="Protein Spotlight">
<link uri="https://web.expasy.org/spotlight/back_issues/083"/>
<text>Tangled - Issue 83 of June 2007</text>
</comment>
<dbReference type="EMBL" id="M12529">
<property type="protein sequence ID" value="AAB59518.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="K00396">
<property type="protein sequence ID" value="AAB59546.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M10065">
<property type="protein sequence ID" value="AAB59397.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050154">
<property type="protein sequence ID" value="AAD02505.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF261279">
<property type="protein sequence ID" value="AAG27089.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314898">
<property type="protein sequence ID" value="BAG37412.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ525876">
<property type="protein sequence ID" value="ACN81314.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003557">
<property type="protein sequence ID" value="AAH03557.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB035149">
<property type="protein sequence ID" value="BAA96080.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12647.1"/>
<dbReference type="PIR" id="A92478">
<property type="entry name" value="LPHUE"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000032.1">
<property type="nucleotide sequence ID" value="NM_000041.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001289617.1">
<property type="nucleotide sequence ID" value="NM_001302688.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001289618.1">
<property type="nucleotide sequence ID" value="NM_001302689.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001289619.1">
<property type="nucleotide sequence ID" value="NM_001302690.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001289620.1">
<property type="nucleotide sequence ID" value="NM_001302691.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.654439"/>
<dbReference type="PDB" id="1B68">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=19-209"/>
</dbReference>
<dbReference type="PDB" id="1BZ4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=40-183"/>
</dbReference>
<dbReference type="PDB" id="1EA8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=19-209"/>
</dbReference>
<dbReference type="PDB" id="1GS9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=19-183"/>
</dbReference>
<dbReference type="PDB" id="1H7I">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=19-209"/>
</dbReference>
<dbReference type="PDB" id="1LE2">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=41-184"/>
</dbReference>
<dbReference type="PDB" id="1LE4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=41-184"/>
</dbReference>
<dbReference type="PDB" id="1LPE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=41-184"/>
</dbReference>
<dbReference type="PDB" id="1NFN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=19-209"/>
</dbReference>
<dbReference type="PDB" id="1NFO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=19-209"/>
</dbReference>
<dbReference type="PDB" id="1OEF">
<property type="method" value="NMR"/>
<property type="chains" value="A=281-304"/>
</dbReference>
<dbReference type="PDB" id="1OEG">
<property type="method" value="NMR"/>
<property type="chains" value="A=285-307"/>
</dbReference>
<dbReference type="PDB" id="1OR2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=19-183"/>
</dbReference>
<dbReference type="PDB" id="1OR3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.73"/>
<property type="chains" value="A=19-183"/>
</dbReference>
<dbReference type="PDB" id="2KC3">
<property type="method" value="NMR"/>
<property type="chains" value="A=19-201"/>
</dbReference>
<dbReference type="PDB" id="2KNY">
<property type="method" value="NMR"/>
<property type="chains" value="A=147-167"/>
</dbReference>
<dbReference type="PDB" id="2L7B">
<property type="method" value="NMR"/>
<property type="chains" value="A=19-317"/>
</dbReference>
<dbReference type="PDBsum" id="1B68"/>
<dbReference type="PDBsum" id="1BZ4"/>
<dbReference type="PDBsum" id="1EA8"/>
<dbReference type="PDBsum" id="1GS9"/>
<dbReference type="PDBsum" id="1H7I"/>
<dbReference type="PDBsum" id="1LE2"/>
<dbReference type="PDBsum" id="1LE4"/>
<dbReference type="PDBsum" id="1LPE"/>
<dbReference type="PDBsum" id="1NFN"/>
<dbReference type="PDBsum" id="1NFO"/>
<dbReference type="PDBsum" id="1OEF"/>
<dbReference type="PDBsum" id="1OEG"/>
<dbReference type="PDBsum" id="1OR2"/>
<dbReference type="PDBsum" id="1OR3"/>
<dbReference type="PDBsum" id="2KC3"/>
<dbReference type="PDBsum" id="2KNY"/>
<dbReference type="PDBsum" id="2L7B"/>
<dbReference type="ProteinModelPortal" id="P02649"/>
<dbReference type="SMR" id="P02649"/>
<dbReference type="BioGrid" id="106845">
<property type="interactions" value="63"/>
</dbReference>
<dbReference type="DIP" id="DIP-1120N"/>
<dbReference type="IntAct" id="P02649">
<property type="interactions" value="33"/>
</dbReference>
<dbReference type="MINT" id="MINT-4999641"/>
<dbReference type="STRING" id="9606.ENSP00000252486"/>
<dbReference type="DrugBank" id="DB00062">
<property type="generic name" value="Human Serum Albumin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00064">
<property type="generic name" value="Serum albumin iodonated"/>
</dbReference>
<dbReference type="iPTMnet" id="P02649"/>
<dbReference type="PhosphoSitePlus" id="P02649"/>
<dbReference type="SwissPalm" id="P02649"/>
<dbReference type="UniCarbKB" id="P02649"/>
<dbReference type="BioMuta" id="APOE"/>
<dbReference type="DMDM" id="114039"/>
<dbReference type="DOSAC-COBS-2DPAGE" id="P02649"/>
<dbReference type="SWISS-2DPAGE" id="P02649"/>
<dbReference type="EPD" id="P02649"/>
<dbReference type="MaxQB" id="P02649"/>
<dbReference type="PaxDb" id="P02649"/>
<dbReference type="PeptideAtlas" id="P02649"/>
<dbReference type="PRIDE" id="P02649"/>
<dbReference type="DNASU" id="348"/>
<dbReference type="Ensembl" id="ENST00000252486">
<property type="protein sequence ID" value="ENSP00000252486"/>
<property type="gene ID" value="ENSG00000130203"/>
</dbReference>
<dbReference type="GeneID" id="348"/>
<dbReference type="KEGG" id="hsa:348"/>
<dbReference type="UCSC" id="uc002pab.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="348"/>
<dbReference type="DisGeNET" id="348"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000130203.9"/>
<dbReference type="GeneCards" id="APOE"/>
<dbReference type="HGNC" id="HGNC:613">
<property type="gene designation" value="APOE"/>
</dbReference>
<dbReference type="HPA" id="CAB008363"/>
<dbReference type="HPA" id="CAB069921"/>
<dbReference type="HPA" id="HPA065539"/>
<dbReference type="HPA" id="HPA068768"/>
<dbReference type="MalaCards" id="APOE"/>
<dbReference type="MIM" id="104310">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="107741">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="143890">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="269600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="611771">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="617347">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P02649"/>
<dbReference type="OpenTargets" id="ENSG00000130203"/>
<dbReference type="Orphanet" id="238616">
<property type="disease" value="Alzheimer disease"/>
</dbReference>
<dbReference type="Orphanet" id="1648">
<property type="disease" value="Dementia with Lewy body"/>
</dbReference>
<dbReference type="Orphanet" id="406">
<property type="disease" value="Heterozygous familial hypercholesterolemia"/>
</dbReference>
<dbReference type="Orphanet" id="412">
<property type="disease" value="Hyperlipoproteinemia type 3"/>
</dbReference>
<dbReference type="Orphanet" id="329481">
<property type="disease" value="Lipoprotein glomerulopathy"/>
</dbReference>
<dbReference type="Orphanet" id="158029">
<property type="disease" value="Sea-blue histiocytosis"/>
</dbReference>
<dbReference type="PharmGKB" id="PA55"/>
<dbReference type="eggNOG" id="ENOG410IVK0">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4111MYC">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00730000111315"/>
<dbReference type="HOGENOM" id="HOG000034006"/>
<dbReference type="HOVERGEN" id="HBG010582"/>
<dbReference type="InParanoid" id="P02649"/>
<dbReference type="KO" id="K04524"/>
<dbReference type="OMA" id="MGSRTRD"/>
<dbReference type="OrthoDB" id="EOG091G0IA5"/>
<dbReference type="PhylomeDB" id="P02649"/>
<dbReference type="TreeFam" id="TF334458"/>
<dbReference type="Reactome" id="R-HSA-3000480">
<property type="pathway name" value="Scavenging by Class A Receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381426">
<property type="pathway name" value="Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8864260">
<property type="pathway name" value="Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8957275">
<property type="pathway name" value="Post-translational protein phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8963888">
<property type="pathway name" value="Chylomicron assembly"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8963901">
<property type="pathway name" value="Chylomicron remodeling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8964026">
<property type="pathway name" value="Chylomicron clearance"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8964058">
<property type="pathway name" value="HDL remodeling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975634">
<property type="pathway name" value="Retinoid metabolism and transport"/>
</dbReference>
<dbReference type="SIGNOR" id="P02649"/>
<dbReference type="ChiTaRS" id="APOE">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P02649"/>
<dbReference type="GeneWiki" id="Apolipoprotein_E"/>
<dbReference type="GenomeRNAi" id="348"/>
<dbReference type="PMAP-CutDB" id="P02649"/>
<dbReference type="PRO" id="PR:P02649"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000130203"/>
<dbReference type="CleanEx" id="HS_APOE"/>
<dbReference type="ExpressionAtlas" id="P02649">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P02649">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0072562">
<property type="term" value="C:blood microparticle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042627">
<property type="term" value="C:chylomicron"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030669">
<property type="term" value="C:clathrin-coated endocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034365">
<property type="term" value="C:discoidal high-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071682">
<property type="term" value="C:endocytic vesicle lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0005788">
<property type="term" value="C:endoplasmic reticulum lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031012">
<property type="term" value="C:extracellular matrix"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903561">
<property type="term" value="C:extracellular vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0034364">
<property type="term" value="C:high-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034363">
<property type="term" value="C:intermediate-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990777">
<property type="term" value="C:lipoprotein particle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034362">
<property type="term" value="C:low-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034361">
<property type="term" value="C:very-low-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001540">
<property type="term" value="F:amyloid-beta binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016209">
<property type="term" value="F:antioxidant activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015485">
<property type="term" value="F:cholesterol binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0017127">
<property type="term" value="F:cholesterol transporter activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008201">
<property type="term" value="F:heparin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008289">
<property type="term" value="F:lipid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005319">
<property type="term" value="F:lipid transporter activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071813">
<property type="term" value="F:lipoprotein particle binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050750">
<property type="term" value="F:low-density lipoprotein particle receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046911">
<property type="term" value="F:metal chelating activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060228">
<property type="term" value="F:phosphatidylcholine-sterol O-acyltransferase activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005543">
<property type="term" value="F:phospholipid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005198">
<property type="term" value="F:structural molecule activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048156">
<property type="term" value="F:tau protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070326">
<property type="term" value="F:very-low-density lipoprotein particle receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097113">
<property type="term" value="P:AMPA glutamate receptor clustering"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0042982">
<property type="term" value="P:amyloid precursor protein metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048844">
<property type="term" value="P:artery morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006874">
<property type="term" value="P:cellular calcium ion homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019934">
<property type="term" value="P:cGMP-mediated signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006707">
<property type="term" value="P:cholesterol catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0033344">
<property type="term" value="P:cholesterol efflux"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042632">
<property type="term" value="P:cholesterol homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008203">
<property type="term" value="P:cholesterol metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034378">
<property type="term" value="P:chylomicron assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034382">
<property type="term" value="P:chylomicron remnant clearance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034371">
<property type="term" value="P:chylomicron remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007010">
<property type="term" value="P:cytoskeleton organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055089">
<property type="term" value="P:fatty acid homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G-protein coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034380">
<property type="term" value="P:high-density lipoprotein particle assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034384">
<property type="term" value="P:high-density lipoprotein particle clearance"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034375">
<property type="term" value="P:high-density lipoprotein particle remodeling"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046907">
<property type="term" value="P:intracellular transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010877">
<property type="term" value="P:lipid transport involved in lipid storage"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042158">
<property type="term" value="P:lipoprotein biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042159">
<property type="term" value="P:lipoprotein catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035641">
<property type="term" value="P:locomotory exploration behavior"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015909">
<property type="term" value="P:long-chain fatty acid transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0007616">
<property type="term" value="P:long-term memory"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034374">
<property type="term" value="P:low-density lipoprotein particle remodeling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051651">
<property type="term" value="P:maintenance of location in cell"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1902430">
<property type="term" value="P:negative regulation of amyloid-beta formation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0030195">
<property type="term" value="P:negative regulation of blood coagulation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043537">
<property type="term" value="P:negative regulation of blood vessel endothelial cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090090">
<property type="term" value="P:negative regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032269">
<property type="term" value="P:negative regulation of cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045541">
<property type="term" value="P:negative regulation of cholesterol biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090370">
<property type="term" value="P:negative regulation of cholesterol efflux"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0061000">
<property type="term" value="P:negative regulation of dendritic spine development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1902951">
<property type="term" value="P:negative regulation of dendritic spine maintenance"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0001937">
<property type="term" value="P:negative regulation of endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051055">
<property type="term" value="P:negative regulation of lipid biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1903001">
<property type="term" value="P:negative regulation of lipid transport across blood brain barrier"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1900272">
<property type="term" value="P:negative regulation of long-term synaptic potentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043407">
<property type="term" value="P:negative regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1901215">
<property type="term" value="P:negative regulation of neuron death"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0010977">
<property type="term" value="P:negative regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902999">
<property type="term" value="P:negative regulation of phospholipid efflux"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0010544">
<property type="term" value="P:negative regulation of platelet activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901627">
<property type="term" value="P:negative regulation of postsynaptic membrane organization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1901630">
<property type="term" value="P:negative regulation of presynaptic membrane organization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0090209">
<property type="term" value="P:negative regulation of triglyceride metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031102">
<property type="term" value="P:neuron projection regeneration"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007263">
<property type="term" value="P:nitric oxide mediated signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097114">
<property type="term" value="P:NMDA glutamate receptor clustering"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0033700">
<property type="term" value="P:phospholipid efflux"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044794">
<property type="term" value="P:positive regulation by host of viral process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:1905908">
<property type="term" value="P:positive regulation of amyloid fibril formation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902004">
<property type="term" value="P:positive regulation of amyloid-beta formation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0030828">
<property type="term" value="P:positive regulation of cGMP biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010875">
<property type="term" value="P:positive regulation of cholesterol efflux"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0010873">
<property type="term" value="P:positive regulation of cholesterol esterification"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060999">
<property type="term" value="P:positive regulation of dendritic spine development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1902952">
<property type="term" value="P:positive regulation of dendritic spine maintenance"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0045807">
<property type="term" value="P:positive regulation of endocytosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905855">
<property type="term" value="P:positive regulation of heparan sulfate binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905860">
<property type="term" value="P:positive regulation of heparan sulfate proteoglycan binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046889">
<property type="term" value="P:positive regulation of lipid biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1903002">
<property type="term" value="P:positive regulation of lipid transport across blood brain barrier"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0032805">
<property type="term" value="P:positive regulation of low-density lipoprotein particle receptor catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051044">
<property type="term" value="P:positive regulation of membrane protein ectodomain proteolysis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902998">
<property type="term" value="P:positive regulation of neurofibrillary tangle assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1901216">
<property type="term" value="P:positive regulation of neuron death"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0010976">
<property type="term" value="P:positive regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051000">
<property type="term" value="P:positive regulation of nitric-oxide synthase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902995">
<property type="term" value="P:positive regulation of phospholipid efflux"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1901628">
<property type="term" value="P:positive regulation of postsynaptic membrane organization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1901631">
<property type="term" value="P:positive regulation of presynaptic membrane organization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0043687">
<property type="term" value="P:post-translational protein modification"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0017038">
<property type="term" value="P:protein import"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0006898">
<property type="term" value="P:receptor-mediated endocytosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905906">
<property type="term" value="P:regulation of amyloid fibril formation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900221">
<property type="term" value="P:regulation of amyloid-beta clearance"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0030516">
<property type="term" value="P:regulation of axon extension"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000822">
<property type="term" value="P:regulation of behavioral fear response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032489">
<property type="term" value="P:regulation of Cdc42 protein signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905890">
<property type="term" value="P:regulation of cellular response to very-low-density lipoprotein particle stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090181">
<property type="term" value="P:regulation of cholesterol metabolic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901214">
<property type="term" value="P:regulation of neuron death"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0048168">
<property type="term" value="P:regulation of neuronal synaptic plasticity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032462">
<property type="term" value="P:regulation of protein homooligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051246">
<property type="term" value="P:regulation of protein metabolic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902947">
<property type="term" value="P:regulation of tau-protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061771">
<property type="term" value="P:response to caloric restriction"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002021">
<property type="term" value="P:response to dietary excess"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000302">
<property type="term" value="P:response to reactive oxygen species"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001523">
<property type="term" value="P:retinoid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043691">
<property type="term" value="P:reverse cholesterol transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007271">
<property type="term" value="P:synaptic transmission, cholinergic"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019433">
<property type="term" value="P:triglyceride catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070328">
<property type="term" value="P:triglyceride homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006641">
<property type="term" value="P:triglyceride metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042311">
<property type="term" value="P:vasodilation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034447">
<property type="term" value="P:very-low-density lipoprotein particle clearance"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034372">
<property type="term" value="P:very-low-density lipoprotein particle remodeling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019068">
<property type="term" value="P:virion assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="InterPro" id="IPR000074">
<property type="entry name" value="ApoA_E"/>
</dbReference>
<dbReference type="Pfam" id="PF01442">
<property type="entry name" value="Apolipoprotein"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0026">Alzheimer disease</keyword>
<keyword id="KW-1008">Amyloidosis</keyword>
<keyword id="KW-0153">Cholesterol metabolism</keyword>
<keyword id="KW-0162">Chylomicron</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0971">Glycation</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0345">HDL</keyword>
<keyword id="KW-0358">Heparin-binding</keyword>
<keyword id="KW-0380">Hyperlipidemia</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0445">Lipid transport</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0558">Oxidation</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0753">Steroid metabolism</keyword>
<keyword id="KW-1207">Sterol metabolism</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0850">VLDL</keyword>
<feature type="signal peptide" evidence="30">
<location>
<begin position="1"/>
<end position="18"/>
</location>
</feature>
<feature type="chain" description="Apolipoprotein E" id="PRO_0000001987">
<location>
<begin position="19"/>
<end position="317"/>
</location>
</feature>
<feature type="repeat" description="1">
<location>
<begin position="80"/>
<end position="101"/>
</location>
</feature>
<feature type="repeat" description="2">
<location>
<begin position="102"/>
<end position="123"/>
</location>
</feature>
<feature type="repeat" description="3">
<location>
<begin position="124"/>
<end position="145"/>
</location>
</feature>
<feature type="repeat" description="4">
<location>
<begin position="146"/>
<end position="167"/>
</location>
</feature>
<feature type="repeat" description="5">
<location>
<begin position="168"/>
<end position="189"/>
</location>
</feature>
<feature type="repeat" description="6">
<location>
<begin position="190"/>
<end position="211"/>
</location>
</feature>
<feature type="repeat" description="7">
<location>
<begin position="212"/>
<end position="233"/>
</location>
</feature>
<feature type="repeat" description="8">
<location>
<begin position="234"/>
<end position="255"/>
</location>
</feature>
<feature type="region of interest" description="8 X 22 AA approximate tandem repeats">
<location>
<begin position="80"/>
<end position="255"/>
</location>
</feature>
<feature type="region of interest" description="LDL receptor binding" evidence="19">
<location>
<begin position="158"/>
<end position="168"/>
</location>
</feature>
<feature type="region of interest" description="Heparin-binding" evidence="29">
<location>
<begin position="162"/>
<end position="165"/>
</location>
</feature>
<feature type="region of interest" description="Heparin-binding" evidence="29">
<location>
<begin position="229"/>
<end position="236"/>
</location>
</feature>
<feature type="modified residue" description="Methionine sulfoxide" evidence="9">
<location>
<position position="143"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by FAM20C" evidence="8 26">
<location>
<position position="147"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="23">
<location>
<position position="26"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="23">
<location>
<position position="36"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation) lysine">
<location>
<position position="93"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="18">
<location>
<position position="212"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="18">
<location>
<position position="307"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="18">
<location>
<position position="308"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="23">
<location>
<position position="314"/>
</location>
</feature>
<feature type="sequence variant" description="In form E5; associated with hyperlipoproteinemia and atherosclerosis; dbSNP:rs121918392." id="VAR_000645" evidence="28">
<original>E</original>
<variation>K</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP3; form E4 Philadelphia and form E5-type; only form E4 Philadelphia is associated with HLPP3; dbSNP:rs201672011." id="VAR_000646" evidence="16">
<original>E</original>
<variation>K</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="sequence variant" description="In LPG; form E2 Kyoto; dbSNP:rs121918399." id="VAR_042734" evidence="10 17">
<original>R</original>
<variation>C</variation>
<location>
<position position="43"/>
</location>
</feature>
<feature type="sequence variant" description="In FH; unknown pathological significance; form E4 Freiburg; dbSNP:rs769452." id="VAR_000647" evidence="11 27">
<original>L</original>
<variation>P</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In form E3 Freiburg; dbSNP:rs28931576." id="VAR_000648">
<original>T</original>
<variation>A</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; confirmed at protein level; dbSNP:rs370594287." id="VAR_014114" evidence="20 36">
<original>Q</original>
<variation>H</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In form E5 Frankfurt." id="VAR_000649">
<original>Q</original>
<variation>K</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" description="In form E5-type; no hyperlipidemia; dbSNP:rs28931578." id="VAR_000650">
<original>P</original>
<variation>R</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence variant" description="In form E3*; dbSNP:rs28931577." id="VAR_000651">
<original>A</original>
<variation>T</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="sequence variant" description="In form E3 Basel; dbSNP:rs937063425." id="VAR_016789" evidence="13">
<original>A</original>
<variation>V</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP3 and AD2; form E3**, form E4, form E4/3 and some forms E5-type; form E3** is associated with HLPP3; form E4 is associated with AD2; dbSNP:rs429358." id="VAR_000652" evidence="11 14 31 32 35">
<original>C</original>
<variation>R</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In FH; unknown pathological significance; form E1 Weisgraber; dbSNP:rs267606664." id="VAR_000653" evidence="27 31">
<original>G</original>
<variation>D</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP3; form E3 Leiden." id="VAR_000654" evidence="25">
<original>G</original>
<variation>GEVQAMLG</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In form E2-type; no hyperlipidemia; dbSNP:rs28931578." id="VAR_000655">
<original>R</original>
<variation>Q</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP3; form E2-type; dbSNP:rs121918393." id="VAR_000657">
<original>R</original>
<variation>C</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP3; form E2 Christchurch; dbSNP:rs121918393." id="VAR_000656" evidence="21 31">
<original>R</original>
<variation>S</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP3; form E3**; dbSNP:rs387906567." id="VAR_000658" evidence="31">
<original>R</original>
<variation>C</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP3 and FH; form E4 Philadelphia and form E2-type; dbSNP:rs769455." id="VAR_000659" evidence="11 16 27">
<original>R</original>
<variation>C</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In E3 Kochi; dbSNP:rs121918397." id="VAR_000660">
<original>R</original>
<variation>H</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In LPG; form E2 Sendai; dbSNP:rs121918397." id="VAR_042735" evidence="34">
<original>R</original>
<variation>P</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP3; form E1 Harrisburg; dbSNP:rs121918394." id="VAR_000662">
<original>K</original>
<variation>E</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP3; form E2**; dbSNP:rs121918394." id="VAR_000661">
<original>K</original>
<variation>Q</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="sequence variant" description="In SBHD and FH; also found in patients with a diagnosis of familial combined hyperlipidemia." id="VAR_035015" evidence="12 15 21 22 24 27">
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In form E3*; dbSNP:rs267606662." id="VAR_000663">
<original>A</original>
<variation>P</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP3; forms E1 Weisgraber, form E2 and form E3**; form E3** is associated with HLPP; dbSNP:rs7412." id="VAR_000664" evidence="11 14 31">
<original>R</original>
<variation>C</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence variant" description="In form E2 Fukuoka; dbSNP:rs267606663." id="VAR_000665">
<original>R</original>
<variation>Q</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" description="In form E2 Dunedin; dbSNP:rs121918395." id="VAR_000666">
<original>R</original>
<variation>C</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In form E2 WG; dbSNP:rs199768005." id="VAR_000667" evidence="33">
<original>V</original>
<variation>E</variation>
<location>
<position position="254"/>
</location>
</feature>
<feature type="sequence variant" description="In HLPP3; form E7 Suita." id="VAR_000668">
<original>EE</original>
<variation>KK</variation>
<location>
<begin position="262"/>
<end position="263"/>
</location>
</feature>
<feature type="sequence variant" description="In form E3 HB and form E4/3; dbSNP:rs267606661." id="VAR_000669" evidence="33 35">
<original>R</original>
<variation>G</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="sequence variant" description="In form E1 HE; requires 2 nucleotide substitutions." id="VAR_000670" evidence="33">
<original>L</original>
<variation>E</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In form E4 PD; dbSNP:rs121918398." id="VAR_000671" evidence="33">
<original>R</original>
<variation>H</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In form E4 HG; dbSNP:rs28931579." id="VAR_000672" evidence="33">
<original>S</original>
<variation>R</variation>
<location>
<position position="314"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="22"/>
<end position="24"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="31"/>
<end position="39"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="40"/>
<end position="42"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="43"/>
<end position="60"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="63"/>
<end position="70"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="73"/>
<end position="96"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="97"/>
<end position="99"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="106"/>
<end position="141"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="143"/>
<end position="145"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="149"/>
<end position="179"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="180"/>
<end position="182"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="187"/>
<end position="190"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="193"/>
<end position="198"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="200"/>
<end position="202"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="209"/>
<end position="217"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="228"/>
<end position="241"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="257"/>
<end position="283"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="286"/>
<end position="303"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="307"/>
<end position="309"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1BZ4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1GS9"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1LE4"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1NFN"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1OEF"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KC3"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L7B"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P08226"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10432380"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11042151"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11095479"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12864777"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12966036"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16094309"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1674745"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18077821"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19838169"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2063194"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22028381"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22481068"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22949395"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23234360"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24267230"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2556398"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26091039"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26802169"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2760009"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3947350"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7068630"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8287539"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8346443"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8488843"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9176854"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9360638"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source ref="10"/>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3283935"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000305"/>
<sequence length="317" mass="36154" checksum="91AFC04210A30689" modified="1986-07-21" version="1" precursor="true">
MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQT
LSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQA
RLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVY
QAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMG
SRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEK
VQAAVGTSAAPVPSDNH
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>